Inogen, Inc.
General ticker "INGN" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $201.8M (TTM average)
Inogen, Inc. follows the US Stock Market performance with the rate: 20.8%.
Estimated limits based on current volatility of 2.0%: low 6.78$, high 7.05$
Factors to consider:
- Total employees count: 766 (-8.2%) as of 2024
- US accounted for 65.1% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Regulatory and compliance, Market competition, Customer concentration, Supply chain disruptions, Economic downturns and volatility
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.48$, 12.75$]
- 2025-12-31 to 2026-12-31 estimated range: [5.12$, 12.00$]
Financial Metrics affecting the INGN estimates:
- Negative: with PPE of -5.7 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: 41.86 < Shareholder equity ratio, % of 58.70 <= 63.39
- Positive: 0.33 < Operating cash flow per share per price, % of 2.90
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Negative: negative Industry operating cash flow (median)
- Positive: -14.38 < Investing cash flow per share per price, % of -6.85
Short-term INGN quotes
Long-term INGN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $377.24MM | $315.66MM | $335.70MM |
| Operating Expenses | $462.48MM | $425.05MM | $378.22MM |
| Operating Income | $-85.24MM | $-109.39MM | $-42.52MM |
| Non-Operating Income | $1.98MM | $7.04MM | $6.04MM |
| R&D Expense | $21.94MM | $20.84MM | $21.61MM |
| Income(Loss) | $-83.27MM | $-102.34MM | $-36.48MM |
| Taxes | $0.50MM | $0.10MM | $-0.59MM |
| Profit(Loss)* | $-83.77MM | $-102.45MM | $-35.89MM |
| Stockholders Equity | $297.41MM | $204.81MM | $173.86MM |
| Inventory | $34.09MM | $21.84MM | $24.81MM |
| Assets | $405.04MM | $326.19MM | $296.19MM |
| Operating Cash Flow | $-37.53MM | $-3.23MM | $5.91MM |
| Capital expenditure | $21.22MM | $26.52MM | $17.09MM |
| Investing Cash Flow | $-10.88MM | $-59.31MM | $-13.97MM |
| Financing Cash Flow | $0.38MM | $0.96MM | $0.27MM |
| Earnings Per Share** | $-3.67 | $-4.42 | $-1.52 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.